Ceftriaxone use in a tertiary care hospital in Kilimanjaro, Tanzania: A need for a hospital antibiotic stewardship programme

Tolbert B. Sonda, Pius G. Horumpende*, Happiness H. Kumburu, Marco van Zwetselaar, Stephen E. Mshana, Michael Alifrangis, Ole Lund, Frank Møller Aarestrup, Jaffu O. Chilongola, Blandina T. Mmbaga, Gibson S. Kibiki

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

66 Downloads (Pure)

Abstract

Excessive use of antibiotics, especially watch group antibiotics such as ceftriaxone leads to emergence and spread of antimicrobial resistance (AMR). In low and middle-income countries (LMICs), antibiotics are overused but data on consumption is scarcely available. We aimed at determining the extent and predictors of ceftriaxone use in a tertiary care university teaching hospital in Kilimanjaro, Tanzania. A hospital-based cross-sectional study was conducted from August 2013 through August 2015. Patients admitted in the medical, surgical wards and their respective intensive care units, receiving antimicrobials and other medications for various ailments were enrolled. Socio-demographic and clinical data were recorded in a structured questionnaire from patients’ files and logistic regression was performed to determine the predictors for ceftriaxone use. Out of the 630 patients included in this study, 322 (51.1%) patients were on ceftriaxone during their time of hospitalization. Twenty-two patients out of 320 (6.9%) had been on ceftriaxone treatment without evidence of infection. Ceftriaxone use for surgical prophylaxis was 44 (40.7%), of which 32 (72.7%) and 9 (20.5%) received ceftriaxone prophylaxis before and after surgery, respectively. Three (6.8%) received ceftriaxone prophylaxis during surgery. Predicting factors for that the health facility administered ceftriaxone were identified as history of any medication use before referral to hospital [OR = 3.4, 95% CI (1.0–11.4), p = 0.047], bacterial infection [OR = 18.0, 95% CI (1.4–225.7, p = 0.025)], surgical ward [OR = 2.9, 95% CI (0.9–9.4), p = 0.078] and medical wards [OR = 5.0, 95% CI (0.9–28.3), p = 0.070]. Overall, a high ceftriaxone use at KCMC hospital was observed. Antimicrobial stewardship programs are highly needed to monitor and regulate hospital antimicrobial consumption, which in turn could help in halting the rising crisis of antimicrobial resistance.

Original languageEnglish
Article numbere0220261
JournalPLOS ONE
Volume14
Issue number8
Number of pages11
ISSN1932-6203
DOIs
Publication statusPublished - 2019

Cite this

Sonda, T. B., Horumpende, P. G., Kumburu, H. H., van Zwetselaar, M., Mshana, S. E., Alifrangis, M., ... Kibiki, G. S. (2019). Ceftriaxone use in a tertiary care hospital in Kilimanjaro, Tanzania: A need for a hospital antibiotic stewardship programme. PLOS ONE, 14(8), [e0220261]. https://doi.org/10.1371/journal.pone.0220261
Sonda, Tolbert B. ; Horumpende, Pius G. ; Kumburu, Happiness H. ; van Zwetselaar, Marco ; Mshana, Stephen E. ; Alifrangis, Michael ; Lund, Ole ; Møller Aarestrup, Frank ; Chilongola, Jaffu O. ; Mmbaga, Blandina T. ; Kibiki, Gibson S. / Ceftriaxone use in a tertiary care hospital in Kilimanjaro, Tanzania : A need for a hospital antibiotic stewardship programme. In: PLOS ONE. 2019 ; Vol. 14, No. 8.
@article{900692d82cca47e5b760cf739872a611,
title = "Ceftriaxone use in a tertiary care hospital in Kilimanjaro, Tanzania: A need for a hospital antibiotic stewardship programme",
abstract = "Excessive use of antibiotics, especially watch group antibiotics such as ceftriaxone leads to emergence and spread of antimicrobial resistance (AMR). In low and middle-income countries (LMICs), antibiotics are overused but data on consumption is scarcely available. We aimed at determining the extent and predictors of ceftriaxone use in a tertiary care university teaching hospital in Kilimanjaro, Tanzania. A hospital-based cross-sectional study was conducted from August 2013 through August 2015. Patients admitted in the medical, surgical wards and their respective intensive care units, receiving antimicrobials and other medications for various ailments were enrolled. Socio-demographic and clinical data were recorded in a structured questionnaire from patients’ files and logistic regression was performed to determine the predictors for ceftriaxone use. Out of the 630 patients included in this study, 322 (51.1{\%}) patients were on ceftriaxone during their time of hospitalization. Twenty-two patients out of 320 (6.9{\%}) had been on ceftriaxone treatment without evidence of infection. Ceftriaxone use for surgical prophylaxis was 44 (40.7{\%}), of which 32 (72.7{\%}) and 9 (20.5{\%}) received ceftriaxone prophylaxis before and after surgery, respectively. Three (6.8{\%}) received ceftriaxone prophylaxis during surgery. Predicting factors for that the health facility administered ceftriaxone were identified as history of any medication use before referral to hospital [OR = 3.4, 95{\%} CI (1.0–11.4), p = 0.047], bacterial infection [OR = 18.0, 95{\%} CI (1.4–225.7, p = 0.025)], surgical ward [OR = 2.9, 95{\%} CI (0.9–9.4), p = 0.078] and medical wards [OR = 5.0, 95{\%} CI (0.9–28.3), p = 0.070]. Overall, a high ceftriaxone use at KCMC hospital was observed. Antimicrobial stewardship programs are highly needed to monitor and regulate hospital antimicrobial consumption, which in turn could help in halting the rising crisis of antimicrobial resistance.",
author = "Sonda, {Tolbert B.} and Horumpende, {Pius G.} and Kumburu, {Happiness H.} and {van Zwetselaar}, Marco and Mshana, {Stephen E.} and Michael Alifrangis and Ole Lund and {M{\o}ller Aarestrup}, Frank and Chilongola, {Jaffu O.} and Mmbaga, {Blandina T.} and Kibiki, {Gibson S.}",
year = "2019",
doi = "10.1371/journal.pone.0220261",
language = "English",
volume = "14",
journal = "P L o S One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "8",

}

Sonda, TB, Horumpende, PG, Kumburu, HH, van Zwetselaar, M, Mshana, SE, Alifrangis, M, Lund, O, Møller Aarestrup, F, Chilongola, JO, Mmbaga, BT & Kibiki, GS 2019, 'Ceftriaxone use in a tertiary care hospital in Kilimanjaro, Tanzania: A need for a hospital antibiotic stewardship programme', PLOS ONE, vol. 14, no. 8, e0220261. https://doi.org/10.1371/journal.pone.0220261

Ceftriaxone use in a tertiary care hospital in Kilimanjaro, Tanzania : A need for a hospital antibiotic stewardship programme. / Sonda, Tolbert B.; Horumpende, Pius G.; Kumburu, Happiness H.; van Zwetselaar, Marco; Mshana, Stephen E.; Alifrangis, Michael; Lund, Ole; Møller Aarestrup, Frank ; Chilongola, Jaffu O.; Mmbaga, Blandina T.; Kibiki, Gibson S.

In: PLOS ONE, Vol. 14, No. 8, e0220261, 2019.

Research output: Contribution to journalJournal articleResearchpeer-review

TY - JOUR

T1 - Ceftriaxone use in a tertiary care hospital in Kilimanjaro, Tanzania

T2 - A need for a hospital antibiotic stewardship programme

AU - Sonda, Tolbert B.

AU - Horumpende, Pius G.

AU - Kumburu, Happiness H.

AU - van Zwetselaar, Marco

AU - Mshana, Stephen E.

AU - Alifrangis, Michael

AU - Lund, Ole

AU - Møller Aarestrup, Frank

AU - Chilongola, Jaffu O.

AU - Mmbaga, Blandina T.

AU - Kibiki, Gibson S.

PY - 2019

Y1 - 2019

N2 - Excessive use of antibiotics, especially watch group antibiotics such as ceftriaxone leads to emergence and spread of antimicrobial resistance (AMR). In low and middle-income countries (LMICs), antibiotics are overused but data on consumption is scarcely available. We aimed at determining the extent and predictors of ceftriaxone use in a tertiary care university teaching hospital in Kilimanjaro, Tanzania. A hospital-based cross-sectional study was conducted from August 2013 through August 2015. Patients admitted in the medical, surgical wards and their respective intensive care units, receiving antimicrobials and other medications for various ailments were enrolled. Socio-demographic and clinical data were recorded in a structured questionnaire from patients’ files and logistic regression was performed to determine the predictors for ceftriaxone use. Out of the 630 patients included in this study, 322 (51.1%) patients were on ceftriaxone during their time of hospitalization. Twenty-two patients out of 320 (6.9%) had been on ceftriaxone treatment without evidence of infection. Ceftriaxone use for surgical prophylaxis was 44 (40.7%), of which 32 (72.7%) and 9 (20.5%) received ceftriaxone prophylaxis before and after surgery, respectively. Three (6.8%) received ceftriaxone prophylaxis during surgery. Predicting factors for that the health facility administered ceftriaxone were identified as history of any medication use before referral to hospital [OR = 3.4, 95% CI (1.0–11.4), p = 0.047], bacterial infection [OR = 18.0, 95% CI (1.4–225.7, p = 0.025)], surgical ward [OR = 2.9, 95% CI (0.9–9.4), p = 0.078] and medical wards [OR = 5.0, 95% CI (0.9–28.3), p = 0.070]. Overall, a high ceftriaxone use at KCMC hospital was observed. Antimicrobial stewardship programs are highly needed to monitor and regulate hospital antimicrobial consumption, which in turn could help in halting the rising crisis of antimicrobial resistance.

AB - Excessive use of antibiotics, especially watch group antibiotics such as ceftriaxone leads to emergence and spread of antimicrobial resistance (AMR). In low and middle-income countries (LMICs), antibiotics are overused but data on consumption is scarcely available. We aimed at determining the extent and predictors of ceftriaxone use in a tertiary care university teaching hospital in Kilimanjaro, Tanzania. A hospital-based cross-sectional study was conducted from August 2013 through August 2015. Patients admitted in the medical, surgical wards and their respective intensive care units, receiving antimicrobials and other medications for various ailments were enrolled. Socio-demographic and clinical data were recorded in a structured questionnaire from patients’ files and logistic regression was performed to determine the predictors for ceftriaxone use. Out of the 630 patients included in this study, 322 (51.1%) patients were on ceftriaxone during their time of hospitalization. Twenty-two patients out of 320 (6.9%) had been on ceftriaxone treatment without evidence of infection. Ceftriaxone use for surgical prophylaxis was 44 (40.7%), of which 32 (72.7%) and 9 (20.5%) received ceftriaxone prophylaxis before and after surgery, respectively. Three (6.8%) received ceftriaxone prophylaxis during surgery. Predicting factors for that the health facility administered ceftriaxone were identified as history of any medication use before referral to hospital [OR = 3.4, 95% CI (1.0–11.4), p = 0.047], bacterial infection [OR = 18.0, 95% CI (1.4–225.7, p = 0.025)], surgical ward [OR = 2.9, 95% CI (0.9–9.4), p = 0.078] and medical wards [OR = 5.0, 95% CI (0.9–28.3), p = 0.070]. Overall, a high ceftriaxone use at KCMC hospital was observed. Antimicrobial stewardship programs are highly needed to monitor and regulate hospital antimicrobial consumption, which in turn could help in halting the rising crisis of antimicrobial resistance.

U2 - 10.1371/journal.pone.0220261

DO - 10.1371/journal.pone.0220261

M3 - Journal article

C2 - 31381579

AN - SCOPUS:85070259559

VL - 14

JO - P L o S One

JF - P L o S One

SN - 1932-6203

IS - 8

M1 - e0220261

ER -